[1]冯智 李毅忠 王俊.八髎穴埋线联合黄芪增液汤治疗结肠慢传输型便秘37例[J].现代中医药,2020,(02):057-61.[doi:10.13424/j.cnki.mtcm.2020.02.016]
 Feng Zhi,Li Yizhong,Wang Jun.Treatment of 37 Cases of Colonic Slow Transit Constipation with Baliao Acupoint Embedding and Huangqi Zengye Decoction[J].Modern Traditional Chinese Medicine,2020,(02):057-61.[doi:10.13424/j.cnki.mtcm.2020.02.016]
点击复制

八髎穴埋线联合黄芪增液汤治疗结肠慢传输型便秘37例()
分享到:

《现代中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2020年02期
页码:
057-61
栏目:
出版日期:
2020-04-22

文章信息/Info

Title:
Treatment of 37 Cases of Colonic Slow Transit Constipation with Baliao Acupoint Embedding and Huangqi Zengye Decoction
文章编号:
1672-0571(2020)02-0057-05
作者:
冯智 李毅忠 王俊
安康市中医医院,陕西安康725000
Author(s):
Feng Zhi Li Yizhong Wang Jun
Ankang TCM Hospital, Ankang China, 725000
关键词:
八髎穴穴位埋线黄芪增液汤便秘
Keywords:
Baliao Acupoint Acupoint catgut embedding Huangqi Zengye Decoction Constipation
分类号:
R256.31
DOI:
10.13424/j.cnki.mtcm.2020.02.016
文献标志码:
B
摘要:
目的探讨八髎穴埋线联合黄芪增液汤对结肠慢传输型便秘的临床疗效及对便秘患者自我生存质量的影响?方法将73例结肠慢传输型便秘患者随机分为2组?治疗组给予八髎穴穴位埋线联合黄芪增液汤口服?对照组给予莫沙比利联合聚乙二醇4000散口服?两组连续治疗45日,观察两组患者治疗前后症状积分?生存质量评分和临床疗效,以及治疗组不良反应情况?结果①两组治疗后主要症状和单项症状积分分别与各组治疗前比较差异有统计学意义(P<0.01),说明中?西医治疗都能显著改善便秘相关症状?治疗组治疗后排便时间积分与对照组治疗后排便时间积分比较,有统计学意义(P<0.05),说明治疗组治疗方案优于对照组治疗方案?治疗组治疗后粪便性状?排便频率?难易程度?腹胀等症状积分与对照组治疗后相关症状积分比较,有显著统计学意义(P<0.01),说明治疗组治疗方案在改善粪便性状?排便频率?难易程度?腹胀等方面显著由于对照组?②治疗组治疗后生存质量积分与治疗前比较,有显著统计学意义(P<0.01),说明本研究方案对患者自我生存质量改善明显?对照组治疗后生存质量积分与治疗前比较,在生理因子方面有统计学意义(P<0.01);对照组在社会心理?担忧?满意度等因子方面,治疗后与治疗前比较无统计学意义(P>0.05),说明对照组治疗方案治疗效果不满意,使患者满意度下降,对患者社会心理?担忧等方面无明显改观?③治疗组所有病例均取得良好疗效,有7例达到临床痊愈;对照组有10例无效,无一例痊愈?治疗组总有效率与对照组比较差异有统计学意义(P<0.01)?④治疗组治疗期间,有2例出现轻度不良反应,有1例出现中度不良反应,相关症状予以对症处理后缓解?结论八髎穴埋线联合黄芪增液汤治疗结肠慢传输型便秘疗效确切,不良反应少,值得临床推广?
Abstract:
Objective To explore the clinical effect of Baliao Acupoint embedding combined with Huangqi Zengye Decoction on slow colonic transit constipation and its effect on the quality of life of patients with constipation. Methods Seventy - three patients with slow colonic constipation were randomly divided into two groups. The treatment group was given Baliao Acupoint embedding and Huangqi Zengye Decoction. The control group was given orally mosapride and polyethylene glycol 4000 powder. The two groups were treated continuously for 45 days, and the symptom score, quality of lifescore, and clinical efficacy of the two groups were observed before and after treatment, as well as the adverse reactions in the treatment group. Results 1. The symptom scores of main symptoms and single symptoms after treatment in the two groups were significantly different from those before treatment in each group ( P < 0. 01) , indicating that both Chinese and Western medicine treatment can significantly improve the symptoms related to constipation. The defecation time score after treatment in the treatment group was statistically significant compared with the defecation time score after treatment in the control group ( P <0. 05) , indicating that the treatment regimen in the treatment group was superior to that in the control group. The scores of stool character, defecation frequency, difficulty degree and abdominal distention in the treatment group were significantly higher than those in the control group ( P <0. 01) , indicating that the treatment group is superior to the control group in improving fecal characteristics, defecation frequency, difficulty, abdominal distention and other aspects. 2. Compared with before treatment, the quality of life score of the treatment group after treatment was statistically significant ( P <0. 01) , indicating that this regimen significantly improved the patients’ self - life quality. The quality of life score of the control group after treatment was statistically significant in terms of physiological factors compared with that before treatment ( P <0. 01) ; the control group had no statistics in terms of social psychology, worry, satisfaction, etc. ( p >0. 05) , indicating that the treatment effect of the control group was unsatisfactory, which reduced the patient’ s satisfaction and did not significantly change the patient’ s social psychology and anxiety. 3. All cases in the treatment group achieved good results, and 7 cases achieved clinical recovery; 10 cases in the control group were ineffective and none were cured. The total effective rate of the treatment group was significantly different from that of the control group ( P <0. 01) . 4. During the treatment of the treatment group, there were 2 cases of mild adverse reactions and 1 case of moderate adverse reactions. The related symptoms were relieved after symptomatic treatment. Conclusion Baliao Acupoint embedding combined with Huangqi Zengye Decoction is effective in treating colonic slow transit constipation and has few adverse reactions, which deserves clinical promotion.

参考文献/References:

[1] Zhao Y F, Ma X Q, Wang R, et al. Epidemiology of functional constipation and comparison with constipation -predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China ( SILC) .[ J] . Alimentary Pharmacology & Therapeutics, 2011, 34( 8) :1020 -1029.
[2]聂玉强,李瑜元.罗马Ⅱ功能性胃肠疾病分类及诊断标准[J].国际内科学杂志,2001,28(4):147-150.
[3]周筭,颜帅,张丹,等.Cajal间质细胞自噬在慢性传输型便秘中的实验研究进展[J].辽宁中医杂志,2018,45(3).660-662.
[4]冯硕,刘绍能.中医药治疗功能性便秘机制的研究进展[J].世界华人消化杂志,2013(6):459-463.
[5]中国中西医结合学会消化系统疾病专业委员会.功能性便秘中西医结合诊疗共识意见(2017年)[J],中国中西医结合消化杂志,2018,26(1):18-26.
[6]柯美云,方秀才,侯晓华.功能性胃肠病:肠-脑互动异常[M].北京:科学出版社,2016:642-653.
[7]《针灸技术操作规范第部分:穴位埋线》项目组.中华人民共和国国家标准(GB/T21709.10-2008)针灸技术操作规范第10部分:穴位埋线[J].中国针灸,2009,29(5):405-406.
[8]郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.
[9] Marquis P, Loge C D L, Dubois D, et al. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire[ J] . Scandinavian Journal of Gastroenterology, 2005, 40( 5) :540 -551.
[10]刘海蓉,张建斌.八髎穴治疗盆底疾病的古代文献分析[J].中国针灸,2016,36(12):1327-1330.
[11]曲牟文,李国栋,洪子夫,等.八髎穴埋线治疗慢传输型便秘30例临床观察[J].中医杂志,2013,54(19):1663-1665.
[12] Agachan F , Chen T , Pfeifer J , et al. A Constipation Scoring System to simplify evaluation and management of constipated patients[ J] . Diseases of the Colon & Rectum,1996, 39( 6) :681 -685.
[13] Thomas G P, Dudding, T. C, Rahbour, G, et al. Sacral nerve stimulation for constipation[ J] . British Journal of Surgery, 2012, 100( 2) :174 -181.
[14]郑建勇,李世森,李前进,等.肠道起搏器治疗顽固性便秘的评价[J].中华结直肠疾病电子杂志,2014(5):25-28.
[15]金洵,丁曙晴,吕兴,等.基于血清5-HT探讨深刺八髎穴对STC模型大鼠结肠动力的近期与远期效应[J].时珍国医国药,2018,29(6):89-72.
[16]冯智,胡忠园,王俊,等.李毅忠运用黄芪增液汤治疗结肠慢传输型便秘经验[J].河南中医,2019,39(1):44-47.

相似文献/References:

[1]左晓林.背俞穴埋线治疗产后失眠疗效观察[J].现代中医药,2018,(06):076.[doi:10.13424/j.cnki.mtcm.2018.06.026]
[2]王 超,韦红梅,黎丽燕.穴位埋线治疗抗精神病药物所致便秘的疗效及对其生活质量的影响[J].现代中医药,2020,(04):060.[doi:10.13424/j.cnki.mtcm.2020.04.014]
[3]岳海宏?张晓峰.坎离交泰方联合穴位埋线治疗绝经前后诸证临床观察[J].现代中医药,2021,(04):118.[doi:10.13424/j.cnki.mtcm.2021.04.027]
[4]周晓玲 王小萌 鲁东莹 郭静.艾灸联合TDP灯照射八髎穴缓解肛肠 疾病术后肛周肿痛临床研究[J].现代中医药,2022,1(05):120.[doi:10.13424/j.cnki.mtcm.2022.05.024]
[5]卫弯郑阿妮 李孝平 赵文堂 于雪珂 姚勇杨华元.穴位植入凝胶研究进展[J].现代中医药,2023,(05):019.[doi:10.13424/j.cnki.mtcm.2023.05.004]

备注/Memo

备注/Memo:
通讯作者:王俊,副主任医师?E-mail:451990140@qq.com
更新日期/Last Update: 1900-01-01